Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.55 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | PNMT | P11086 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | LTA | P01374 | 2/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.36 |
| ▸ | RAD51 | Q06609 | 2/20 | 0.36 |
| ▸ | RAD1 | O60671 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL483888 | 0.82 | MIF (0.67) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL7390143 | 0.82 | MIF (0.41) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL7387579 | 0.80 | P2RY6 (0.45) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL9963471 | 0.80 | MIF (0.39) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL11053294 | 0.80 | MIF (0.44) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL2824472 | 0.80 | MIF (0.44) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL9425791 | 0.80 | MIF (0.44) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL1457225 | 0.80 | MIF (0.44) | MIFP2RY6CA1CA2PNMT | |
| SCHEMBL1020699 | 0.80 | MIF (0.44) | MIFP2RY6CA1CA2PNMT | |
| Bitoscanate SCHEMBL157128 | 0.79 | MIF (0.72) | MIFP2RY6CA1CA2PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3581600-B1 | RESIN LENS AND PREPARATION METHOD THEREFOR | EFIRM NEW MAT CO LTD (CN) | 2025-01-08 | — | — | EP | claimed |
| US-11548971-B2 | Method for producing a resin lens from a polyisocyanate and release agent at reduced pressure | YIFENG NEW MATERIALS CO., LTD. (CN) | 2023-01-10 | — | — | US | claimed |
| US-20210221940-A1 | RESIN LENS AND METHOD FOR PRODUCING THE SAME | SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD. (CN) | 2021-07-22 | — | — | US | claimed |
| US-20230317919-A1 | DEPOSITION OF FILMS ONTO BATTERY MATERIAL POWDERS | CORESHELL TECHNOLOGIES, INC. | 2023-10-05 | — | — | US | disclosed |
| EP-4205193-A1 | DEPOSITION OF FILMS ONTO BATTERY MATERIAL POWDERS | Coreshell Technologies, Inc. (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11548971-B2 | Method for producing a resin lens from a polyisocyanate and release agent at reduced pressure | YIFENG NEW MATERIALS CO., LTD. (CN) | 2023-01-10 | — | — | US | disclosed |
| WO-2022047268-A1 | DEPOSITION OF FILMS ONTO BATTERY MATERIAL POWDERS | CORESHELL TECHNOLOGIES, INC. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20210221940-A1 | RESIN LENS AND METHOD FOR PRODUCING THE SAME | SHANDONG EFIRM BIOCHEMISTRY AND ENVIRONMENTAL PROTECTION CO., LTD. (CN) | 2021-07-22 | — | — | US | disclosed |
| US-20150344613-A1 | POLYTHIOUREA COMPOSITIONS AND METHODS OF USE | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-03 | — | — | US | disclosed |
| US-5310916-A | Trifunctional agents useful as irreversible inhibitors of A1-adenosine receptors | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344613-A1 | POLYTHIOUREA COMPOSITIONS AND METHODS OF USE | PNMT, SRM, PUF60 | MIF 2203/4885P2RY6 3010/4885CA1 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.